This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08549/identifier/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08549/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08549/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08549/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08549/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08549
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08549 n14:DB08549
dcterms:title
(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER
adms:identifier
n8:99445020 n9:SK2 n10:5327153 n11:4484395 n12:DB08549
n3:IUPAC-Name
n4:271B62EB-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B62F1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B62F0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B62ED-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B62EE-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B62EF-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B62E9-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B62E7-363D-11E5-9242-09173F13E4C5 n4:271B62EA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B62E8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B62F7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B62F8-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B62F2-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B62F3-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B62F5-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B62F4-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B62F6-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B62FD-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B62FF-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6300-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B62FC-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B62FB-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B62FE-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B62EC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B62F9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B62FA-363D-11E5-9242-09173F13E4C5